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Hyperparathyroidcrisisisararemanifestationofparathyroiddisease.Wepresentthecaseofa53-year-oldgentlemanwithareview
of the current literature. He presented in acute renal failure with epigastric pain and vomiting. His serum-corrected calcium
(CCa2+) was raised at 5.2mmol/L, in addition to a massively raised parathyroid hormone (PTH) level (3957ng/L). Ultrasound
studies of the neck revealed a 2cm well-deﬁned mass inferoposterior to right thyroid lobe. CT scans of the neck showed a
normal mediastinum and conﬁrmed no associated lymphadenopathy. Having undergone medical resuscitation for 9 days, a neck
exploration revealed a cystic mass, which was excised. Histological investigations revealed a 9.25g, cystic parathyroid adenoma
with no features of malignancy. His PTH and CCa2+ returned to normal postoperatively. This suspicious presentation of benign
disease, including a marked elevation in PTH, highlights the challenges facing the endocrine surgeon in dealing with parathyroid
disease.
1.Introduction
Primary hyperparathyroidism is a rare disease, with hyper-
parathyroid crisis being one of its unusual manifestations.
Large rises in PTH levels in benign parathyroid disease
are unusual and have been associated with more sinister
diseases [1]. We discuss a case of a patient with a benign
cystic parathyroid adenoma presenting in sinister fashion
with, in particular, a massively raised serum PTH level only
previously seen in malignant disease [2].
2.CaseReport
A 53-year-old gentleman presented with a 2-week history
of worsening epigastric pain, vomiting, and constipation.
He reported mild confusion but no loss of consciousness.
There was no history of polyuria or polydipsia. He reported
longstanding gastroesophageal reﬂux symptoms but no
other abdominal history. His medical history was negative
for depression and renal calculi. There was no history
of carcinoma or any radiotherapy treatment of any kind.
He reported no signiﬁcant family history. On examination
he was pale with dry mucous membranes. His chest and
abdominal examination were unremarkable. There was no
evidenceofanybonypainandnopalpablelumpsintheneck.
At admission, he was tachycardic and hypotensive with
an increased respiratory rate. He was in acute renal fail-
ure, with an elevated urea (19.5mmol/L) and creatinine
(272µmol/L). Liver function tests were normal. Laboratory
tests revealed a markedly elevated serum-corrected calcium
level (CCa2+) of 5.20mmol/L (normal range 2.12–2.65) and
a parathyroid hormone (PTH) level of 3957ng/L (normal
range 12–75). Vitamin D levels were normal. A myeloma
screen was negative. An ECG showed that he was in normal
sinus rhythm and a chest radiograph was unremarkable.
GiventheacutepresentationandmassivelyelevatedPTHlev-
els, the major concern was a possible malignant parathyroid
lesion. An ultrasound scan of his neck revealed a 2cm well-
deﬁned oval hypoechoic mass posterior and inferior to right
thyroid lobe (Figure 1). A CT scan of the neck conﬁrmed
the 2cm nodule as stated which abutted the right tracheal
margin, with no associated lymphadenopathy and a normal
mediastinum (Figure 2).
The patient underwent initial conservative management
with aggressive intravenous ﬂuid resuscitation, vitamin
D replacement, intravenous loop diuretic treatment, and2 Case Reports in Medicine
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Figure 1: USS neck revealing 3.69cm×2.11cm lesion in right side
of neck.
 
Figure 2: CT neck showinglarge right sided neck lesion.
intravenous bisphosphonate therapy. On day 9, biochemical
markershadimproved(Urea5.3,Creatinine179),andCCa2+
had fallen to 2.99mmol/L. The patient underwent a neck
exploration on day 10. During the exploration, the right
inferior gland was found to be large, cystic, soft, and of a
brown colour. There was a no evidence of local invasion
and no lymphadenopathy. As such, a diagnosis of adenoma
was made. Intraoperative PTH assay is not routinely used
at our unit and as such was not performed. The right
inferior parathyroid gland was excised. The right superior
parathyroid gland was normal, and the contralateral neck
was not explored.
Histological investigations revealed a 3.5cm × 2cm ×
1.5cm encapsulated parathyroid adenoma weighing 9.25g,
composed of chief and oxyphil cells with cystic change. The
Ki-67 proliferative index was low (1-2%). There was no
local, capsular, or vascular invasion and no other features
suggestive of malignancy. Given the suspicious clinical
picture, the report was further conﬁrmed at another centre.
The patient recovered well postoperatively, with PTH
levels falling to 45ng/L within a day. Subsequent recovery
included a period of hypocalcaemia with a raised Alkaline
Phosphatase (ALP), which resolved with calcium replace-
ment within a month.
3.Discussion
Primary hyperparathyroidism is a rare disease, where the
majority of patients now present asymptomatically after
biochemical testing which shows a mildly raised serum
CCa2+ and marginally elevated PTH level [3]. However, our
case highlights two important aspects of parathyroid disease
that the authors would like to explore further. Firstly the
diﬃculty in diagnosis of a patient with a markedly raised
PTH and secondly the diﬃculty faced preoperatively in the
management of a patient presenting with hyperparathyroid
crisis.
Preoperative and even histological diﬀerentiation be-
tween benign or malignant pathology is often diﬃcult, and
appropriate management requires judgement at the time
of surgery as malignant lesions will need more radical
procedures. The features suggestive of malignant lesions at
the time of surgery would include adherence due to ﬁbrosis,
local inﬁltration, or lymph node involvement. There has
been recent work into Preoperative diagnosis based on bio-
chemical grounds with a raised CCa2+ and PTH increasing
the index of suspicion for malignant disease suggesting that
serum PTH levels are mildly elevated in benign disease,
but carcinoma causes levels up to 10 times that of normal
[1] .T of u r t h e rs t r e s st h eb e n e ﬁ to fP T Hi np r e o p e r a t i v e
diagnosis, Robert et al. suggested that a PTH level <4t i m e s
the upper limit of normal excludes a malignancy [4]. Other
studies support the above trend—a recent case series looking
at solitary adenomas causing asymptomatic disease have
derived mean values of Preoperative PTH as 186 [5]a n d
165ng/L [6], while research into carcinoma show higher
PTH levels of 714 [2] and 1220ng/L [7]. This consolidates
the unusual nature of a PTH level of 3957ng/L in an
adenoma withno radiological,Intraoperative,orhistological
evidence of malignancy. CCa2+ is usually no greater than
1mmol/dl above normal ranges in benign disease compared
to over4 times the upper limit of normal in malignant lesion
[1]. Tumour mass has also been shown to correlate with
diagnosis. The average adenoma weighs 1g, but the average
values for carcinoma weight are approximately 4g [8, 9]
correlating well with Robert’s study (1.3g versus 4.9g) [4].
Our case is unusual in that we report a benign adenoma with
PTH,CCa2+,andweightthatareallsuggestiveofparathyroid
carcinoma.
There are several published cases where benign disease
presents suspiciously and PTH in particular reaches levels
associated with carcinoma. These include parathyroid cysts,
those presenting in developing countries, patients with
oxyphil adenomas, and those presenting, as demonstrated
in our case, in hyperparathyroid crisis. Parathyroid cysts
are rare neck lesions [10]. Case reports and series inves-
tigating these have reported a wide range of PTH levels,Case Reports in Medicine 3
ﬂuctuating from normal to 2250ng/L [11] with overlapping
clinical and biochemical presentations of parathyroid cysts
with carcinoma [12], making Preoperative diﬀerentiation
diﬃcult but important as surgical management will diﬀer.
In developing countries, benign adenomas are reported to
present with a similar biochemical proﬁle to carcinoma.
Agarwal et al. reported PTH levels in benign disease similar
to that in cancerous disease [13], attributing this to the
late presentation of the disease and nutritional deﬁciencies.
Oxyphil adenomas have been suggested to cause 3% of
all adenomas. Recent case reports have suggested markedly
elevated PTH levels up to 1291ng/L [14], although often
there are no systemic features suggestive of patients in
crises.
Our case of parathyroid crisis is a further example of
suspiciously elevated PTH levels, suggestive of parathyroid
carcinoma. A recent study published in 2008 looking at
just under 300 patients undergoing procedures for hyper-
parathyroidism showed 2.8% present in crisis [15]. These
patients present with 3-4 times higher PTH levels than
those with asymptomatic disease and over 10 times that
of normal (up to 1770ng/L), consistent with PTH levels
in malignant disease. They found that 88% were caused
by underlying adenoma. Bleeding into adenomas that have
undergone cystic degeneration is a well-recognised cause
of crisis with histopathological ﬁndings revealing a large
adenoma with cystic spaces ﬁlled with haemorrhagic ﬂuid
[16]. There is a suggested trend where the weight of tumour
excised duringa hyperparathyroid crisis is heavierthan those
with asymptomatic disease (means 7.5g versus 1.6g) [15].
Our case is an example of this, where a patient in crisis has
an adenomaweight much higher thantypicalbenign disease.
Management of hyperparathyroid crisis has traditionally
involved an emergency parathyroidectomy within 72 hours
of presentation, which has a mortality of up to 14% [15, 17].
However, recent evidence published by Phitayakorn and
McHenry [15] supports an early excision after a period of
optimisation, rather than emergency surgery. Once volume
depletion is corrected, loop diuretic therapy and intravenous
bisphosphonate therapy can be initiated [18]. This relatively
rapid reduction in CCa2+ thereby acts as a “bridge to
surgery,” with a mean interval between presentation and
operative intervention of 8 days [15]. This is not dissimilar
to our interval of 10 days, thereby allowing for appropriate
operative workup and management of concurrent medical
problems. Surgical management of patients presenting with
hyperparathyroid crisis secondary to adenomatous disease is
eﬀective, with a reported success rate of 92% [19]. While
medical optimisation preoperatively is largely successful
[15], there are reports where medical management has failed
anddiseasehasonlyrespondedtodeﬁnitivesurgicalmanage-
ment [20]. Dialysis has also been used as a successful adjunct
to medical therapy, in the interval between presentation and
surgery [21]. With appropriate medical management prior
to surgical excision, mortality rates have fallen, with rates
for patients presenting in hyperparathyroid crisis reported as
2.8% [18].
In summary, our case involves a gentleman presenting
in hyperparathyroid crisis with a massively raised serum
PTH level that the authors believe to be one of the highest
reportedinbenigndiseasepublishedtodate.Itrepresentsthe
presentation ofbenigncystic adenomamimicking malignant
disease. It also reinforces the importance of prompt initial
medical management, Preoperative diagnostic and localising
studies, and sound operative judgement, highlighting the
diﬃculties facing the endocrine surgeon when dealing with
lesions of the parathyroid gland.
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